Endpoints News 生物医药· Max Bayer·· 3 天前AI 评分45
Helus Pharma III 期抑郁症试验取得积极结果
Helus Pharma notches successful Phase 3 depression readout
AI 导读
Helus Pharma 的主打药物在 III 期试验中显示比安慰剂更能改善抑郁症状,但投资者反应略显谨慎。
正文
Helus Pharma, part of the budding class of psychedelics companies, said its lead drug improved depression symptoms compared to placebo, but investors appeared slightly skittish …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news